(3.238.173.209) 您好!臺灣時間:2021/05/12 13:53
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果

詳目顯示:::

我願授權國圖
: 
twitterline
研究生:吳聰賢
研究生(外文):S. T. Wu
論文名稱:信義鄉全民健保成人健檢資料分析探討---高血脂症,痛風,肥胖
論文名稱(外文):The research of " National Health Insurance-adult health examination data" in Sin-I country--hyperlipidemia, gout and obesity.
指導教授:吳芳鴦
指導教授(外文):F. Y. Wu
學位類別:碩士
校院名稱:中國醫藥學院
系所名稱:環境醫學研究所
學門:醫藥衛生學門
學類:公共衛生學類
論文種類:學術論文
論文出版年:2001
畢業學年度:89
語文別:中文
論文頁數:53
中文關鍵詞:高膽固醇血症高三酸甘油脂血症身體質量指數肥胖中風心臟病糖尿病痛風
外文關鍵詞:hypercholesterolemiahypertriglyceridemiabody mass indexobesityCVACHDDMgout
相關次數:
  • 被引用被引用:6
  • 點閱點閱:482
  • 評分評分:系統版面圖檔系統版面圖檔系統版面圖檔系統版面圖檔系統版面圖檔
  • 下載下載:0
  • 收藏至我的研究室書目清單書目收藏:4
利用南投縣信義鄉接受「全民健保成人健檢」者的資料,做分析統計,其目的在探討高血脂症、痛風及肥胖與相關因子的關係。民國89年南投縣信義鄉民接受「全民健保成人健檢」者,共有2591人,男性1251人,女性1340人,其中閩南人866人,客家人346人,外省人38人,布農族1308人,泰雅族7人,鄒族22人,阿美族1人,魯凱族1人,不明族別者2人,因為是成人健檢,年齡均是超過40歲的中老年人。
男性原住民血清膽固醇值平均值188.6mg/dl,男性非原住民血膽固醇值平均值190.6mg/dl,女性原住民血清膽固醇平均值193.1mg/dl,女性非原住民血清膽固醇值平均值198.3mg/dl,男女兩性非原住民均高於原住民,後者達統計學意義;男性原住民血清三酸甘油脂平均值222.5mg/dl,男性非原住民142.1 mg/dl,女性原住民血清三酸甘油脂平均值191.1mg/dl,女性非原住民血清三酸甘油脂平均值142.4mg/dl,相反地,男女兩性原住民均高於非原住民,兩者均達統計學意義。
原住民高膽固醇血症佔總數39.0%,非原住民高膽固醇血症佔總數38.6%,不管男女合計、或分開計算,原住民與非原住民間均不達顯著性差異,不分族群,女性比男性有較高機率得高膽固醇血症;原住民高三酸甘油脂血症佔總數30.6%,非原住民高三酸甘油脂血症佔總數16.2%,不管男女合計、或分開計算,原住民與非原住民間均達顯著性差異;以高血脂症來說,不管男女合計、或分開計算,原住民比非原住民有較高機率得高血脂症。
我們的研究亦發現原住民比非原住民有較高的尿酸值,男性8.2 mg/dl比7.0 mg/dl,女性7.0mg/dl比5.8mg/dl,均達顯著意義;另外身體質量指數也是原住民高於非原住民,男性26.5比23.4,女性27.4比24.3,均達顯著意義。
也發現原住民均比非原住民有較高機率罹患高尿酸血症、痛風、高血脂症、和肥胖症,此些疾病具有某種相關性,兩者種族上的差異,似乎顯示遺傳基因所佔的重要性。
高血脂症與中風、心臟病沒有相關性,只有高三酸甘油脂血症與高血壓、糖尿病有相關性。其他健檢資料探討,如高血脂症、痛風和肥胖與相關因子之分析,將在結果部分詳述。
The research of the relationship among the hyperlipidemia, gout, obesity and the risk factors was carried out from the community population of SIN-I country,Nan-To county, by over-forty years old adults including of Taiwanese aboriginals and non-aboriginals who accepted the “National health insurance-adult health examination”
There were 2591 persons consisted of 1251 males and 1340 female that accepted the “National health insurance-adult health examination” from SIN-I country,Nan-To county,at 2000. The races were multiple patters including of 866 Fukien, 346 Hakka, 38 extra-provincial, 1308 Bunun, 7 Ataya, 22 Tsou, 1 Amei, 1 Rukai,and 2 unknown. According to the law of “National health insurance”, all people accepted the “adult health examination” were over-forty years old.
Non-aboriginals had higher serum cholesterol value than Aboriginals,at male 190.6mg/dl to 188.6mg/dl,at female 198.3mg/dl to 193.1mg/dl ,only female significantly statistically.Contrarily aboriginals had higher serum triglyceride value than non- Aboriginals, at male 222.5mg/dl to 142.1mg/dl,at female 191.1mg/dl to 142.4mg/dl , both female and male significantly statistically.
Aboriginals had higher hypercholesterolemia probability 39.0% than non- aboriginals 38.6% , both female and male non-significantly statistically. Aboriginals had also higher hypertriglyceridemia probability 30.6% than non- Aboriginals 16.2%, both female and male significantly statistically.
Aboriginals had higher serum uric acid value than non- Aboriginals, at male 8.2mg/dl to 7.0mg/dl,at female 7.0mg/dl to 5.8mg/dl, both female and male significantly statistically. Aboriginals had also higher body mass index than non- Aboriginals, at male 26.5 to 23.4, at female 27.4 to 24.3, both female and male significantly statistically.
We found out that aboriginals had higher serum uric acid value, serum triglyceride value, and BMI than non- aboriginals. We also found out that aboriginals had higher prevalence rate of hyperuricemia, gout, hyperlipidemia, and obesity than non- aboriginals. There diseases were relative each other that seem show the importance of hereditary factors. In general, many reports revealed the significant relation among the hyperlipidemia and CVA, CHD. Our results didn’t revealed the relation, except the relation of hypertriglyceridemia and hypertension, DM .
Other data will be stated detailly in the result.
中國醫藥學院碩士班研究生論文指導教授推薦書………………..1
中國醫藥學院碩士班研究生論文口試委員審定書………………..2
博碩士論文電子檔案上網授權書……………………………………3
致謝…………………………………………………………………..4
目錄…………………………………………………………………..5
中文摘要……………………………………………………………..8
英文摘要……………………………………………………………..9
名詞界定……………………………………………………………..11
南投縣信義鄉社區概況……………………………………………..12
第壹章、 前言……………………………………………………..13
第貳章、文獻探討…………………………………………………..17
第一節、膽固醇與三酸甘油脂………………………………..17
第二節、脂蛋白………………………………………………..18
第三節、表面脂蛋白…………………………………………..19
第四節、表面脂蛋白E基因…………………………………..21
第五節、肥胖與血脂肪………………………………………..23
第六節、痛風、尿酸與血脂肪、高血壓、糖尿病…………..24
第參章、材料與方法…………………………………………………27
第一節、 研究對象…………………………………………….27
第二節、 研究方法…………………………………………….27
第三節、 統計方法 ………………………………………..27
第肆章、結果…………………………………………………………29
第伍章、討論…………………………………………………………31
第陸章、結論…………………………………………………………33
參考文獻………………………………………………………………36
表目錄
1. 洪泳泉,秀傳紀念醫院新陳代謝科主任,運動、脂蛋白、冠狀心臟病,當代醫學,第二十卷,第七期,83-87,中華民國八十二年七月。
2. 許惠恆,國防醫學院內科副教授,吸煙與血脂肪,三軍總醫院新陳代謝科主治醫師,當代醫學,第十九卷,第二期,41-43,中華民國八十一年二月。
3. 吳寶榮,陸軍802總醫院內科住院醫師,顧長生,陸軍802總醫院心臟科主任,李文俊,陸軍802總醫院內科部部主任,如何防止冠狀動脈粥狀硬化,當代醫學,第二十一卷,第四期,7-14,中華民國八十三年四月。
4. Yuji Moriwaki, Tetsuya Yamamoto, Sumio Takahashi, Zenta Tsutsumi, Kazuya Higashino (1995).Apolipoprotein E phenotypes in patients with gout : relation with hypertriglyceridaemia.Annals of the Rheumatic Diseases 1995; 54:351-354.
5. 陳保羅,台北市立忠孝醫院,洪傳岳,台北榮民總醫院暨陽明醫學院臨床醫學研究所,脂肪酸與缺血性心臟病,當代醫學,第二十一卷,第十一期,53-56,中華民國八十三年十一月。
6. C. Roche, P. Boutin, C. Dina, G. Gyapay, A. Basdevant, J. Hager, B. Guy-Grand, K. Clement, P. Froguel. Genetic studies of neuropeptide Y and neuropeptide Y receptors Y1 and Y5 regions in morbid obesity. Diabetologia (1997) 40: 671-675.
7. 論壇健康促進與疾病預防委員會文獻回顧研析計劃,兒童之肥胖問題與對策,國家衛生研究院論壇,中華民國89年。
8. Harrison’s Principles of Internal Medicine.Seventh Edition.台灣版,中華民國六十四年二月出版,原著者:Harrison’s,發行人:華毛幼琪,發行者:大學圖書出版社有限公司,臺北市羅斯福路四段十六號。
9. Current Medical Diagnosis and Treatment.台灣版,中華民國六十四年七月三十一日出版,原著者:Milton J.Chatton,發行人:李瑞麟,發行所及印刷所:美亞書版股份有限公司,台北市南京東路一段四十八號。
10. Barbara Livingstone. Epidemiology of childhood obesity in Europe. Eur J Pediatr (2000) 159: [Suppl 1] S14-S34.
11. C. T. Chou and J. S. Lai. The epidemiology of hyperuricaemia and gout in Taiwan aborigines. British Journal of Rheumatology 1998; 37: 258-262.
12. Suzanne Marcus, Sigrid Sahlen, Bo Lambert, Goran Wettrell. A missense mutation in the hypoxanthine phosphoribosyltransferase gene in a pediatric patient with hyperuricemia. Acta. Pediatr. 82:758-63.1993.
13. Takashi Igarashi, Shigehiko Kamoshita. Carrier Detection of Partial Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency by Analysis with BamHI Restriction Fragment Length Polymorphisms and Oligonucleotide Probes. Pediatric Research Vol.27,No. 4,1990.
14. Karen Stanley Williams, MD, James G. Hankerson, MD, Monique Ernst, MD, PhD, Alan Zametkin, MD. Use of Propofol Anesthesia during Outpatient Radiographic Imaging Studies in Patients with Lesch-Nyhan Syndrome. J. Clin. Anesth., vol.9, February 1997.
15. Joanne McManaman, MD, David A. Tam, MD. Gabapentin for Self-Injurious Behavior in Lesch-Nyhan Syndrome. Pediatric Neurology. Vol.20 No.5. 1999.
16. Wen-Jane Lee, Hsien-Ming Lee, Ching-Shiang Chi, Min-Tzu Yang, Hsiao-Yi Lin, Wen-Han Lin. Genetic Analysis of HPRT Mutation of Lesch-Nyhan Syndrome in Chinese Family.
17. Jun Tohyama, Eiji Nanba,Kousaku Ohno. Hypoxanthine-guanine phosphoribosyltransferase(HPRT)deficiency:Identification of point mutation in Japanese patients with Lesch-Nyhan Syndrome and hereditary gout and their permanent expression in an HPRT-deficiency mouse cell line. Human genetics. Springer-Verlag 1994.
18. Alcolol dehydrogenase and aldehyde dehydrogenase genotypes and alcoholism among Taiwanese aborigines. Biol Psychiatry 1997;41:703-709.
19. 鄢盛X,周新,林其燧,宋耀虹. 漢族人群載脂蛋白E基因多態性與冠狀動脈粥樣硬化性心臟病關係的研究.Natl Med China,October 1998,Vol. 78,No.10臨床研究.
20. 中山醫學院生物化學研究所碩士論文,指導教授:蕭松瑞教授,研究生:謝銘薰,馬栗樹皮素與原兒茶酸抑制低密度脂蛋白質氧化作用及機轉之研究(Inhibitory effect and action mechanisms of esculetin and protocatechuic acid on LDL oxidaion),中華民國八十九年六月。
21. 許惠恆,國防醫學院內科副教授,三軍總醫院新陳代謝科主治醫師,簡介脂蛋白(a),當代醫學,第十八卷,第六期,40-43,中華民國八十年六月。
22. Henry Houlden, Richard Crook, Karen Duff, Mike Hutton, John Collinge, Penelope Roques, Martin Rossor, John Hardy. Apolipoprotein E alleles but neither apolipoprotein B nor apolipoprotein AⅠ/CⅢ alleles are associated with late onset, familial Alzheimer’s disease. Neuroscience Letters 188 (1995)202-204.
23. 行政院衛生署編著,丁予安、何橈通、祝年豐、許惠恆、張仙平、鄭啟源、潘文涵、蕭明熙、謝炎堯著作,行政院衛生署中老年病防治系列叢書(2),高血脂防治手冊-國人血脂異常診療及預防指引,遠流出版事業股份有限公司,1997年12月1日出版。
24. 中華民國飲食手冊,飲食手冊編審小組,行政院衛生署印製,中華民國八十三年七月
25. 洪泳泉,秀傳紀念醫院新陳代謝科主治醫師,曾兼任長庚紀念醫院新陳代謝科主治醫師,現任美國長堤榮民醫院脂肪研究中心研究員,增加高密度脂蛋白的合成可刺激逆向膽固醇運輸,進而減低動脈硬化的發生,當代醫學,第十八卷,第三期,19-22,中華民國八十年三月。
26. 編著者:主編/丁克祥,副編/邱仲峰,鑑修/呂鋒洲,SOD生物醫學淺論-Introduction of SOD in biology and medicine,發行者:藝軒圖書出版社,發行人:彭賽蓮,總經銷:藝軒圖書文具有限公司,中華民國八十五年三月第一版。
27. Kailash Prasad, M.D., Ph.D., F.I.C.A., Subrahmanyam V. Mantha, Ph.D., Jawahar Kalra, M.D., Ph.D., F.I.C.A., Paul Lee, M.Sc. Hypercholesterolemia-induced oxidative stress in heart and its prevention by vitamin E. International Journal of Angiology 6: 13-17 (1997).
28. Y. K. Goh, J. A. Jumpsen, E. A. Ryan, M. T. Clandinin. Effect of ω3 fatty acid on plasma lipids, cholesterol and lipoprotein fatty acid content in NIDDM patients. Diabetologia (1997) 40: 45-52.
29. 洪泳泉,美國長堤榮民醫院脂肪研究中心研究員,對國際膽固醇教育計劃(NCEP)的沉思:需要將高密度脂蛋白膽固醇列入常規檢查中嗎?當代醫學,第十八卷,第九期,9-15,中華民國八十一年二月。
30. 編譯者:劉華茂,生理學,發行人:華毛幼琪,發行者:大學圖書出版社公司,經銷處:華西書局,中華民國五十九年十二月出版。
31. Keith Tolfrey, Ian Gordon Campbell, Andrew Mark Jones. Intra-individual variation of plasma lipids and lipoproteins in prepubescent children. Eur J Appl Physiol (1999) 79: 449-456.
32. D. S. Sharp, C. M. Burchfiel, B. L. Rodriguez, A. R. Sharrett, P. D. Sorlie, S. M. Marcovina. Apolipoprotein A-1 predicts coronary heart disease only at low concentrations of high-density lipoprotein cholesterol: an epidemiological study of Japanese-Americans. Diabetologia (1999) 42: 1413-1416.
33. Jorg Heeren, Dirk S. Steinwaerder, Frank Schnieders, Gunther Cichon, Michael Strauss, Ulrike Beisiegel. Nonphysiological overexpression of low-density lipoprotein receptors causes pathological intracellular lipid accumulation and the formation of cholesterol and cholesteryl ester crystals in vitro. J Mol Med (1999) 77:735-743.
34. 許惠恆,國防醫學院內科副教授,三軍總醫院新陳代謝科主治醫師,高三酸甘油脂血症的重要性-由赫爾辛基心臟試驗談起,當代醫學,第二十卷,第九期,13-18,中華民國八十二年九月。
35. Peter W.F.Wilson,MD;Richard H.Myers,PhD;Martin G.Larson,ScD;Jose M. Ordovas,PhD;Philip A.Wolf,MD;Ernst J.Schaefer,MD (1994).Apolipoprotein E alleles,Dyslipidemia,and coronary heart disease.The Framingham offspring study. JAMA,December 7,1994-Vol 272,No.21
36. Trond P.Leren,Anne-Lise Borresen,Kare Berg,Ingvar Hjermann and Paul Leren (1985).Increased frequency of the apolipoprotein E-4 isoform in male subjects with multifactorial hypercholesterolemia.Clinical Genetics 1985: 27:458-462.
37. Gerard Siest,Thierry Pillot,Anne Regis-Bailly,Brigitte Leininger-Muller,Josiane Steinmetz,Marie-Madeleine Galteau,and Sophia Visvikis(1995).Apolipoprotein E: An important gene and protein to follow in laboratory medicine. Clin. Chem. 41/8, 1068-1086(1995)
38. Pascale Richard,Ginette Thomas,Maria Pascual de Zulueta,Jean-Luc De Gennes, Michel Thomas,Andre Cassaigne,Gilbert Bereziat,and Albert Iron(1994).Common and rare genotypes of human apolipoprotein E determined by specific restriction profiles of polymerase chain reaction-amplified DNA. Clin.Chem.40/1,24-29 (1994)Molecular pathology.
39. Philip R.Wenham,Clive R.Newton,and William H.Price(1991).Analysis of apolipoprotein E genotypes by the amplification refractory mutation system.Clin.Chem.37/2,241-244(1991)
40. F.M.van Bockxmeer,C.D.S.Mamotte(1992).Apolipoproteinε4 homozygosity in young men coronary heart disease.The Lancet VOL 340:OCT 10,1992.
41. Sadao Takahashi,Koji Oida,Minoru Ookubo,Jinya Suzuki,Mitsuyuki Kohno, Toshio Murase,Tokuo Yamamoto,Tsuguhiko Nakai(1996).Very low density lipoprotein receptor binds apolipoprotein E2/2 as well as apolipoprotein E3/3. FEBS(Federation of European Biochemical Societies) Letters 386 (1996) 197- 200.
42. Tsuo-Hung Lan,Chen-Jee Hong,Jen-Yu Chen,and Cho-Boon Sim(1997).Apolipo protein E-ε4 frequency in patients with schizophrenia.Biol Psychiatry(Society of Biological Psychiatry) 1997;42;225-227.
43. M.Ilyas Kamboh,Rhobert W.Evans,Christopher E.Aston(1995).Genetic effect of apolipoprotein(a) and apolipoprotein E polymorphisms on plasma quantitative risk factors for coronary heart disease in American black women.Atheroclerosis 117 (1995) 73-81.
44. D.A.Janneke Brouwer,Jasper J.van Doormaal,Frits A.J.Muskiet(1996).Clinical chemistry of common apolipoprotein E isoforms.Journal of chromatography B, 678 (1996) 23-41.
45. C. Jolivalt, B. Leininger-Muller, R. Drozdz, J. W. Naskalski, G. Siest. Apolipoprotein E is highly susceptible to oxidation by myeloperoxidase, an enzyme present in the brain. Neuroscience Letters 210(1996) 61-64.
46. H. Kim-Motoyama, K. Yasuda, T. Yamaguchi, N. Yamada, T. Katakura, Alan R. Shuldiner, Y. Akanuma, Y. Ohashi, Y. Yazaki, T. Kadowaki. A mutation of the β3-adrenergic receptor is associated with visceral obesity but decreased serum triglyceride. Diabetologia (1997) 40: 469-472.
47. Jason Faller, M. D., and Irving H. Fox, M. D. Ethenol-induced hyperuricemia. Evidence for increased urate production by activation of adenine nucleotide turn-
over. The New England Journal of Medicine. Vol. 307 No.26, 1982: 1598-1602.
48. William M. Mikkelsen, M. D., H. J. Doge, M. D., M. P. H. and Hans Valkenburg, M. D., with the technical assistance of Scott Himes. The distribution of serum uric acid values in a population unselected as to gout or hyperuricemia. American Journal of Medicine. Volume 39, August 1965.
49. David S. Freedman, David F. Williamson, Elaine W. Gunter, and Tim Byers. Relation of serum uric acid to mortality and ischemic heart disease. The NHANES Ⅰepidemiologic follow-up study. American Journal of Epidemiology Vol. 141, No. 7, 1995.
50. Elaine B. Feldman, M. D., and Stanley L. Wallace, M. D. Hypertriglyceridemia in gout. Circulation, Volume, ⅩⅩⅠⅩ, April 1964.
51. J. Edwin Seegmiller, M. D., Leonard Laster, M. D., and R. Rodney Howell, M. D. Biochemistry of uric acid and its relation to gout (concluded). The New England Journal of Medicine. Vol. 268. No. 15. Apr. 11, 1963.
52. W. Jeffery Fessel, M. D. High uric acid as an indicator of cardiovascular disease. Independence from obesity. American Journal of Medicine. Volume 68, March 1980.
53. Allen R. Myers, M. D., Frederick H. Epstein, M. D., H. J. Dodge, M. D., M. P. H. and William M. Mikkelsen, M. D. The relationship of serum uric acid to risk factor in coronary heart disease. American Journal of Medicine. Vol. 45, October 1968, 520-528.
54. 編輯部,罕見的膽固醇疾患之基因治療,當代醫學,第十九卷,第五期,55,中華民國八十一年五月。
55. 潘如濱,台北榮民總醫院內科部心臟內科主治醫師,心臟血管疾病與血脂研究的新進展,臨床醫學,第四十二卷,第三期,163-169,中華民國八十七年九月。
56. Vanessa S. Mattevi, Carlos E. A. Coimbra Jr, Ricardo V. Santos, Francisco M. Salzano, Mara H. HUTZ. Association of the low-density lipoprotein receptor gene with obesity in native American populations.Hum Genet (2000) 106: 546-552.
57. L. T. Dalgaard, T. I. A. Sorensen, T. Andersen, T. Hansen, O. Pedersen. An untranslated insertion variant in the uncoupling protein 2 gene is not related to body mass index and changes in body weight during a 26-year follow up in Danish Caucasian men. Diabetologia (1999) 42: 1413-1416.
58. S. Otabe, K. Clement, C. Dina, V. Pelloux, B. Guy-Grand, P. Froguel, F. Vasseur. A genetic variation in the 5’ flanking region of the UCP3 gene is associated with body mass index in human in interaction with physical activity. Diabetologia (2000) 43: 245-249.
59. Robert D. Abbott, Frederick N. Brand, William B. Kannel, and William P.Castelli. Gout and coronary heart disease: The Framingham study.
60. Cuno S.P.M.Uiterwaal,Jacqueline C.M.Witteman,Willy-Anne H.J.van Stiphout, Xeno H.Krauss,Anthony M.de Bruijn,Albert Hofman,Diederick E.Grobbee(1996). Lipoproteins and apolipoproteins in young and familial risk of coronary athero sclerosis.Atherosclerosis 122 (1996) 235-244.
61. Seung Ho Hong,Junghan Song,Do Hoon Lee,and Jin Q Kim(1998).Lack of association between apolipoprotein H polymorphism and plasma lipid levels in Koreans.Clinical biochemistry,Vol.31,No.4,281-283,1998.
62. Sathanur R.Srinivasan,Christian Ehnholm,Wendy A.Wattigney,Gerald S.Berenson (1996).Influence of apolipoprotein E polymorphism on the tracking of childhood levels of serum lipids and apolipoproteins over a 6-year period.The Bogalusa heart study.Atherosclerosis 127 (1996) 73-79.
63. Mercedes Muros,Carmen Rodriguez-Ferrer(1996).Apolipoprotein E polymorphism Influence on lipids,apolipoproteins and Lp(a) in a Spanish population underexpressing apo E4.Atherosclerosis 121 (1996) 13-21
64. Srikanth Damarju,MD;Qun-Tao Yu,MD;Faye Safavi,BS;and Ali J.Marian,MD (1995). Apolipoproteinε4 is not a genetic risk factor for coronary artery disease or restenosis after percutaneous transluminal coronary angioplasty.The American journal of cardiology Vol.75 June 1, 1995.
65. Guoping Wu,Jiana Yuan,Donald B.Hunninghake(1998).Effect of human apolipo protein E isoforms on plasma lipids,lipoproteins and apolipoprotens in apolipo protein E-deficient mice.Atherosclerosis 141 (1998) 287-296.
66. Antonio de Padua Mansur, MD, Joyce Annicchino-Bizzacchi,MD, Desiderio Favarato,MD, Solange Desiree Avakian, MD, Luiz Antonio Machado Cesar, MD, and Jose Antonio Franchini Ramires, MD. Angiotensin-Converting Enzyme and Apolipoprotein B Polymorphisms in Coronary Artery Disease. The American Journal Of Cardiology Vol.85 May 1, 2000.
67. A. E. Clatworthy,W. Stockinger, R. H. Christie, W. J. Schneider, J. Nimpf, B. T. Hyman, and G. W. Rebeck. Expression and Alternate Splicing of Apolipoprotein E Receptor 2 in Brain. Neuroscience Vol.90, No. 3. pp.903-911, 1999.
68. Roberto Gambino, Gianluca Ruiu, Gianfrano Pagano, Maurizio Cassader. The binding of apolipoprotein H (β2-Glycoprotein Ⅰ)to lipoprteins.Prostaglandins and other lipid mediators 57(1999)351-359.
69. Uwe Beffert, Marc Danik, Pascale Krzywkowski, Charles Ramassamy, Fouad Berrada, Judes Poirier. The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer’s disease. Brain Research Reviews 27(1998)119-142.
70. Cesare R. Sirtori, MD. PhD. Evaluation of Lipoproteins / Apolipoproteins as Therapeutic Agents for the Treatment of Vascular and Nonvascular disease. The American Journal of Cardiology. Vol.81(8A) April 23, 1998.
71. Philippe Bertrand, Judes Poirier, Tomiichiro Oda, Caleb E. Finch, Giulio Maria Pasinetti. Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease. Molecular Brain Research. 33 (1995) 174-178.
QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top
1. 林柏亭,〈清代台灣畫家林朝英〉,《雄獅美術》,第96期(1979年2月)
2. 林柏亭,〈談明清師古臨摹的風氣對台灣早期書畫的影響〉,《雄獅美術》,第154期(1983年12月)
3. 胡丙申,〈從清代南部臺灣的教育說起到現在南縣的教育〉,《南瀛文獻》,第1卷第2期(1953年9)
4. 黃秀政,〈書院與臺灣社會〉,《臺灣文獻》,第31卷第3期
5. 林文龍,〈清代臺灣書院講席彙錄〉,《臺灣文獻》,第42卷第2期
6. 黃秀政,〈談臺灣史料的類別與利用〉,《臺灣文獻》,第40卷第4期
7. 李容福,〈清代游宦臺灣之浙江人士〉,《臺灣文獻》,第23卷第4期(1972年12月)
8. 盛成,〈臺灣文化教育與大陸〉,《臺灣風物》,第11卷第2期(1961年1月)
9. 黃天橫,〈清代台南府城名書畫展記實〉,《藝術家》,第2號(1975年7月)
10. 黃天橫,〈清代台南十大書法家〉,《雄獅美術》,第29期(1973年7月)
11. 崔詠雪,〈臺灣明清書畫概論〉,《臺灣美術》,第39期(1998年1月)
12. 李銘宗,〈台灣書法三百年─台灣主體書學新論域之建構〉,《美育》,101期(1999年8月)
13. 張光賓,〈林宗毅先生捐贈宋朱子書易繫辭冊述略〉,《故宮文物月刊》,第1卷第2期(1983年5月)
14. 葉英,〈周芸皋事略〉,《臺南文化》,新7期(1979年6月)
15. 盧嘉興,〈清代台灣藝術家林朝英〉,《雄獅美術》,第28期(1973年6月)
 
系統版面圖檔 系統版面圖檔